Intra-Cellular Therapies Stock Soars to All-Time High of $128.01
In a remarkable display of market confidence, Intra-Cellular Therapies Inc. (NASDAQ:ITCI) stock has reached an all-time high, touching a price level of $128.01. According to InvestingPro data, the ...
Steady M&A Deals To Begin 2025, Disappointing IPOs So Far
A few notable health care deals along with M&A in the AI-adjacent and reshoring themes occurred in January. Read more here.
The M&A boom of 2025 is just getting started — and here are 5 potential targets
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...